Accessibility Menu
Terumo logo

Terumo(OTC) TRUMF

Market Cap$20.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+68%
5 Year-28%
1 Year-21%
1 Month+8%
$17.01
+0.00%
+0.00Today
Terumo last closing stock price
MetricPriceDate
Last closeUSD 13.692026-08-13
Terumo stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.86%USD 15.362026-08-06
1 month+8.31%USD 12.642026-07-13
3 month+18.06%USD 11.602026-05-13
Year to date+4.73%USD 13.072025-12-31
1 year-21.1%USD 17.352025-08-13
3 year-4.49%USD 14.332023-08-14
5 year-28.22%USD 19.072021-08-13
Since inception+68.25%USD 8.142003-07-31

Terumo Financials at a Glance

Market Cap

$20.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.19T

Net Income (TTM)

¥164.68B

EPS (TTM)

$0.72

P/E Ratio

19.06

Dividend

$0.20

Beta (Volatility)

0.27 (Low)

Price

$17.01

Volume

685

Open

$16.42

Previous Close

$13.69

Daily Range

$16.42 - $17.01

52-Week Range

$11.49 - $20.39

Estimated Earnings Date

Aug 7, 2026

TRUMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terumo

Terumo Corporation is a global medical technology company specializing in the development, manufacturing, and distribution of a wide array of healthcare products and equipment. Founded in 1921 and headquartered in Tokyo, Japan, Terumo operates across three key segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies.

Products and Services
  • Cardiac and vascular products including stents and catheters
  • Medical care solutions such as syringes and infusion pumps
  • Blood and cell technologies for blood collection and processing
Growth Outlook
  • Revenue growth of 10.5% year-over-year in the latest quarter
  • Strong demand for vascular products driving market expansion
  • Investment in R&D to enhance product offerings and innovation
Financial Highlights
  • Trailing twelve months (TTM) revenue of 1.2 trillion JPY
  • Net income of 26.5 billion JPY in the latest quarter
  • Operating cash flow of 89.5 billion JPY, indicating strong liquidity
Terumo Corporation has established itself as a leader in the medical technology sector, with a diverse product portfolio that addresses critical healthcare needs. The company's focus on innovation and quality has positioned it well for future growth, particularly in the vascular and blood management markets. Recent financial performance reflects a robust operational framework, with significant revenue and net income growth, underscoring the company's ability to generate value. The strong operating cash flow further enhances its financial stability, providing a solid foundation for continued investment in research and development. As healthcare demands evolve, Terumo's commitment to advancing medical technology remains a key driver of its long-term success.
AI Generated • Aug 4, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

31,185

CEO

Hikaru Samejima, MBA

Website

www.terumo.co.jp

Headquarters

Tokyo, TY 151-0072, JP

TRUMF Financials

Key Financial Metrics (TTM)

Gross Margin

53.03%

Operating Margin

16.90%

Net Income Margin

13.90%

Return on Equity

10.60%

Return on Capital

9.18%

Return on Assets

6.93%

Earnings Yield

5.25%

Dividend Yield

1.43%

Payout Ratio

26.87%

Stock Overview

Market Cap

$20.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.48B

Volume

685

Avg. Volume

1.33K

Financials (TTM)

Gross Profit

¥629.63B

Operating Income

¥200.55B

EBITDA

¥299.21B

Operating Cash Flow

¥273.74B

Capital Expenditure

-¥81.23B

Free Cash Flow

¥192.50B

Cash & ST Invst.

¥312.36B

Total Debt

¥386.65B

Terumo Performance Analysis

Terumo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 6,054,862,693-3.3%
20242024-03-31JPY 6,383,499,4035.4%
20252025-03-31JPY 6,796,776,0386.5%
20262026-03-31JPY 7,511,190,78610.5%
Terumo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-307.3%
Q32025-12-316.5%
Q42026-03-311.8%
Q12026-06-302.4%
Terumo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.44-15.9%
20242024-03-31JPY 0.4912.7%
20252025-03-31JPY 0.524.7%
20262026-03-31JPY 0.6118.0%
Terumo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-15.4%
Q32025-12-31-8.5%
Q42026-03-31-19.9%
Q12026-06-30166.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

¥309.56B

+19.1%

Gross Profit

¥177.25B

+21.8%

Gross Margin

57.26%

N/A

Market Cap

$20.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$647.56K

N/A

Employees

31,185

N/A

Net Income

¥69.92B

+67.1%

EBITDA

¥95.34B

+23.7%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

¥312.36B

+52.9%

Total Debt

¥386.65B

+85.1%

Accounts Receivable

¥223.94B

+23.0%

Inventory

¥338.64B

+12.5%

Long Term Debt

¥208.00B

+59.0%

Short Term Debt

¥178.64B

+128.8%

Return on Assets

6.93%

N/A

Return on Invested Capital

10.20%

N/A

Free Cash Flow

¥61.42B

+292.6%

Operating Cash Flow

¥73.94B

+126.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDMHFSartorius Stedim Biotech S.A.
$208.48+3.67%
SAUHYStraumann Holding AG
$12.58-0.08%
SAUHFStraumann Holding AG
$128.25+0.00%
SUVPFSartorius AG
$270.29+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.35+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.53-0.01%
INTCIntel
$102.81-0.02%
ONDSOndas
$9.35+0.05%

Questions About TRUMF

What is the current price of Terumo?

Terumo is trading at $17.01 per share.

What is the 52-week range for Terumo?

Over the past 52 weeks, Terumo has traded between $11.49 and $20.39.

How much debt does Terumo have?

As of the most recent reporting period, Terumo reported total debt of ¥2.40B.

How much cash does Terumo have on hand?

Terumo reported ¥1.94B in cash and cash equivalents in its most recent financial results.

What is Terumo’s dividend yield?

Terumo currently has a dividend yield of 1.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services